PS-132-The acetyl-CoA carboxylase inhibitor PF-05221304 exerts direct effects on hepatic inflammation and fibrosis independent of benefits on steatosis.
Saved in:
| Title: | PS-132-The acetyl-CoA carboxylase inhibitor PF-05221304 exerts direct effects on hepatic inflammation and fibrosis independent of benefits on steatosis. |
|---|---|
| Authors: | Ross, Trenton, Kelly, Kenneth, Rinaldi, Anthony, Lech, Matthew, Martinez, Robert, Crowley, Collin, Gonzalez, Santos Carvajal, Boucher, Magalie, Shanthappa, Dinesh Hirenallur, Morin, Jeffrey, Opsahl, Alan C., RVargas, Sarah, Bence, Kendra, Pfefferkorn, Jeffrey A, Esler, William |
| Source: | Journal of Hepatology. Apr2019 Supplement, Vol. 70, pe86-e86. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
